Quantitative analysis of efficacy and safety of LABA/LAMA fixed-dose combinations in the treatment of stable COPD

OBJECTIVE: This study aimed to quantitatively compare the efficacy and safety of long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) for the treatment of stable chronic obstructive pulmonary disease (COPD), especially in terms of their loss of effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yiwen, Lv, Yinghua, Liu, Hongxia, Zheng, Qingshan, Li, Lujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743917/
https://www.ncbi.nlm.nih.gov/pubmed/35001708
http://dx.doi.org/10.1177/17534666211066068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743917/
https://www.ncbi.nlm.nih.gov/pubmed/35001708
http://dx.doi.org/10.1177/17534666211066068

Ejemplares similares